Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Red Blood Cells”

742 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 742 results

Not applicableEnded earlyNCT00607061
What this trial is testing

Synthesis of Glutathione From Low Birth Weight Newborn Babies

Who this might be right for
Low Birth Weight
Nantes University Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01362595
What this trial is testing

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

Who this might be right for
Diamond Blackfan AnemiaBlackfan Diamond SyndromeDBA+2 more
Northwell Health 55
Not applicableStudy completedNCT07664072
What this trial is testing

Single Effort in Air Temperature of Minus 10°C

Who this might be right for
Healthy
University School of Physical Education, Krakow, Poland 30
Testing effectiveness (Phase 2)Study completedNCT00065156
What this trial is testing

Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality

Who this might be right for
Myelodysplastic Syndromes
Celgene 148
Not applicableNot Yet RecruitingNCT07773597
What this trial is testing

Prognostic Value Enhancement Of Sequential Organ Failure Assessment )SOFA( Score by Neutrophil-Lymphocyte Ratio and Red Cell Distribution Width in Cardiogenic Shock Patients.

Who this might be right for
Cardiogenic Shock
Sohag University 150
Large-scale testing (Phase 3)UnknownNCT03871244
What this trial is testing

Pilot Optimizing Transfusion Thresholds in Critically-ill Children With Anaemia

Who this might be right for
Anemia
St. Justine's Hospital 120
Not applicableNot Yet RecruitingNCT07502781
What this trial is testing

Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants

Who this might be right for
Extremely Premature InfantAnemia NeonatalBlood Transfusion+6 more
Hospital Clinic of Barcelona 176
Not applicableLooking for participantsNCT06944067
What this trial is testing

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Human Genome Research Institute (NHGRI) 50
Not applicableWithdrawnNCT06575634
What this trial is testing

Exercise Therapy on Rheological Functions of Erythrocyte in Hemodialysis

Who this might be right for
Hemodialysis Complication
Chang Gung Memorial Hospital
Not applicableStudy completedNCT01735357
What this trial is testing

Differential Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Platelet, Endothelial and Vascular Function

Who this might be right for
Healthy
King's College London 48
Not applicableStudy completedNCT02232412
What this trial is testing

Monitoring the Effect of Red Blood Cell Transfusion on Cerebral Oxygen Saturation With Near Infrared Spectroscopy (NIRS) in Critically Ill Patients

Who this might be right for
Effect of RBC Transfusions on Cerebral Oxygen Saturation
Johann Wolfgang Goethe University Hospital 25
Post-approval studies (Phase 4)Ended earlyNCT00350519
What this trial is testing

The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery

Who this might be right for
Hemostasis, Surgical
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 37
Testing effectiveness (Phase 2)Study completedNCT04477850
What this trial is testing

Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in Chinese and Japanese Participants With Ring Sideroblasts Who Require Red Blood Cell Transfusions

Who this might be right for
Myelodysplastic Syndromes
Celgene 30
Testing effectiveness (Phase 2)Study completedNCT03900715
What this trial is testing

An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion

Who this might be right for
Myelodysplastic Syndromes
Celgene 21
Testing effectiveness (Phase 2)Ended earlyNCT02189889
What this trial is testing

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

Who this might be right for
AnemiaCardiovascular Disease
University of Texas Southwestern Medical Center 5
Large-scale testing (Phase 3)Study completedNCT03459287
What this trial is testing

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

Who this might be right for
Anemia
Cerus Corporation 581
Not applicableStudy completedNCT07307872
What this trial is testing

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more
Amoneta Diagnostics SAS 150
Not applicableStudy completedNCT00285506
What this trial is testing

The Effect of Contrast Media on Erythrocytes in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Medical University of South Carolina 20
Large-scale testing (Phase 3)Study completedNCT00270114
What this trial is testing

The Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)

Who this might be right for
AnemiaBlood TransfusionOrthopedic Procedures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 55
Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.
Next Page